Livforsakringsbolaget Skandia’s Allergan Inc AGN Stock Holding History

Livforsakringsbolaget Skandia’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-29,375	Closed	-$6.25M	–	680
2014 Q4	$6.25M	Sell	29,375 -9,700	-25%	-$1.93M	0.29%	70
2014 Q3	$6.96M	Sell	39,075 -5,600	-13%	-$930K	0.26%	84
2014 Q2	$7.56M	Buy	44,675 +2,000	+5%	+$311K	0.27%	83
2014 Q1	$5.3M	Buy	42,675 +39,975	+1,481%	+$4.87M	0.2%	120
2013 Q4	$300K	Buy	+2,700	New	+$258K	0.19%	125

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Livforsakringsbolaget Skandia's AGN Position: Q1 2015 in Review

Livforsakringsbolaget Skandia sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 29,375 shares — an estimated $6.25M sold.

Livforsakringsbolaget Skandia first reported a position in AGN in Q4 2013 and held it in 5 quarters. The position peaked at $7.56M in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Livforsakringsbolaget Skandia reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Livforsakringsbolaget Skandia sold 29,375 Allergan Inc shares in Q1 2015, an estimated $6.25M.
Livforsakringsbolaget Skandia first reported a position in Allergan Inc in Q4 2013 and held it in 5 quarters.
Livforsakringsbolaget Skandia's Allergan Inc position peaked at $7.56M in Q2 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Livforsakringsbolaget Skandia's 13F filing for Q1 2015, filed 15 May 2015.